Santos Gets $18.72 Billion Takeover Offer From Adnoc-Led Consortium Australia's second-largest producer of oil and natural gas received the offer from a consortium led by Abu Dhabi's national oil ...

The Japanese steelmaker agreed to pay $14.1 billion to buy the Pittsburgh company in 2023. The CEO's embrace of nascent AI technology is a shift from the company's early days when it used ...

23andMe struck a deal last month with Regeneron Pharmaceuticals Inc., but Wojcicki complained about the bidding process, ...

Anne Wojcicki won a bid to purchase the genetic testing platform through her nonprofit TTAM Research Institute. The $305M deal was part of a bankruptcy auction, beating out offers from Regeneron ...

Also this week, more than two dozen states sued 23andMe to challenge the sale of its customers’ private data. The states argue the company must obtain explicit consent from its ...

The California-based nonprofit founded by the former 23andMe CEO is set to close the $305 million deal in coming weeks.

Several states have joined a lawsuit against 23andme. They say bankruptcy shouldn't allow the genetic testing company to sell ...

Welcome to the future, folks—where AI is regulated, genetic testing companies have more plot twists than a soap opera, and ...

Beleaguered genetic testing company 23andMe announced Friday that it has reached an agreement to sell itself to TTAM Research ...

A.I. may push ad creatives from producing to consulting. At Cannes, Monks, a marketing technology agency, will showcase a new ...

Ah, New York. The city that never sleeps is now the city that never lets AI sleep soundly, either. In a world where AI is ...

Anne Wojcicki, the co-founder and former CEO of 23andMe, will purchase the bankrupt company’s assets for $305 million, the genetic testing company said Friday. Regeneron Pharmaceuticals had agreed to ...